Skip to content
10-K

Annual Report

AOXING PHARMACEUTICAL COMPANY, INC.

0001096906-16-001934

← back to feed
Filed
Oct 5, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Sep 27, 2016 76.21M sh
Shares Diluted FY 2016 · Jun 30, 2016 75.47M sh
Shares Diluted FY 2016 · Jun 30, 2015 63.17M sh
Capex FY 2016 · Jun 30, 2016 $117.86K
Capex FY 2016 · Jun 30, 2015 $2.71M
Operating Cash Flow FY 2016 · Jun 30, 2016 −$534.99K
Operating Cash Flow FY 2016 · Jun 30, 2015 $3.03M
Short Term Debt FY 2016 · Jun 30, 2016 $11.07M
Short Term Debt FY 2016 · Jun 30, 2015 $12.48M
Stockholders Equity FY 2016 · Jun 30, 2016 $19.14M
Stockholders Equity FY 2016 · Jun 30, 2015 $11.24M
Current Liabilities FY 2016 · Jun 30, 2016 $37.82M
Current Liabilities FY 2016 · Jun 30, 2015 $41.24M
Current Assets FY 2016 · Jun 30, 2016 $26.87M
Current Assets FY 2016 · Jun 30, 2015 $21.1M
Total Assets FY 2016 · Jun 30, 2016 $56.23M
Total Assets FY 2016 · Jun 30, 2015 $53.04M
Eps Diluted FY 2016 · Jun 30, 2016 $0.03
Eps Diluted FY 2016 · Jun 30, 2015 $0.09
Eps Basic FY 2016 · Jun 30, 2016 $0.03
Eps Basic FY 2016 · Jun 30, 2015 $0.09
Sga Expense FY 2016 · Jun 30, 2016 $3.07M
Sga Expense FY 2016 · Jun 30, 2015 $2.75M
Rd Expense FY 2016 · Jun 30, 2016 $3.14M
Rd Expense FY 2016 · Jun 30, 2015 $337.07K
Net Income FY 2016 · Jun 30, 2016 $2.06M
Net Income restated FY 2016 · Jun 30, 2015 $5.49M
Operating Income FY 2016 · Jun 30, 2016 $6.23M
Operating Income FY 2016 · Jun 30, 2015 $8.7M
Gross Profit FY 2016 · Jun 30, 2016 $24.55M
Gross Profit FY 2016 · Jun 30, 2015 $19.79M
Cost Of Revenue FY 2016 · Jun 30, 2016 $7.78M
Cost Of Revenue FY 2016 · Jun 30, 2015 $5.69M